Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans

NCT05173831 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Transfer of Sponsorship

Conditions

PTSD

Interventions

DRUG: Midomafetamine
BEHAVIORAL: Therapy

Sponsor

Resilient Pharmaceuticals